Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Sinergi Multi Lestarindo Tbk. (SMLE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Sinergi Multi Lestarindo Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Sinergi Multi Lestarindo Tbk. trades at Rp128 (market cap 302.66B, 13.94M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. and Sinergi Multi Lestarindo Tbk. are close in size by market cap, and Sinergi Multi Lestarindo Tbk. is more actively traded (13.94M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | SMLE | |
|---|---|---|
Market Cap | 310.75B | 302.66B |
Volume | 963.6K | 13.94M |
Lot | 9.64K | 139.35K |
Turnover | 217.67M | 1.79B |
Average Price | 225.89 | 128.36 |
Value | 217.67M | 1.79B |
Indicative Equilibrium Price | 226 | 128 |
Indicative Equilibrium Volume | 1K | 17 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Sinergi Multi Lestarindo Tbk.
PT Sinergi Multi Lestarindo Tbk (the Company) was established based on Deed No. 5 dated March 18, 2013 by Aryadi, S.H., M.Kn., Notary in Tangerang. PT Sinergi Asia Corporindo is the parent entity of the Company and Siu Min is the ultimate beneficiary owner of the Company.
Read more on SMLE →
